While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
FDA approves third insulin biosimilar Merilog to ease U.S. supply shortage FDAs latest insulin biosimilar approval aims to mitigate ongoing supply challenges in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback